Use of cryoprotectant-depleted allogeneic peripheral blood stem cells for transplantation

References

• Cutler C, Antin JH. Peripheral blood stem cells for allogeneic transplantation: a review. Stem Cells 2001;19:108–17.
   PubMed Web of Science ®Google Scholar
• Frey NV, Lazarus HM, Goldstein SC. Has allogeneic stem cell cryopreservation been given the ‘clod shoulder’? An analysis of the pros and cons of using frozen versus fresh stem cell products in allogeneic stem cell transplantation. Bone Marrow Transplant 2006;38:399–405.
   PubMed Web of Science ®Google Scholar
• Kim DH, Jamal N, Saragosa R, Loach D, Wright J, Gupta V, et al.. Similar outcome of cryopreserved allogeneic peripheral stem cell transplants (PBSCT) compared to fresh allografts. Biol Blood Marrow Transplant 2007;13:1233–43.
   PubMed Web of Science ®Google Scholar
• Kessinger A, Schmit-Pokorny K, Smith D, Armitage J. Cryopreservation and infusion of autologous peripheral blood stem cells. Bone Marrow Transplant 1990;5(Suppl 1):25–7.
   PubMedGoogle Scholar
• Williams SF, Bitran JD, Richards JM, DeChristopher PJ, Barker E, Conant J, et al.. Peripheral blood-derived stem cell collections for use in autologous transplantation after high dose chemotherapy: an alternative approach. Bone Marrow Transplant 1990;5:129–33.
   PubMed Web of Science ®Google Scholar
• Jacobs P, Wood L, Horak S. Collection and cryopreservation of human stem and progenitor cells for bone marrow transplantation. J Clin Apher 1991;6:54–8.
   PubMedGoogle Scholar
• Harada M, Taniguchi S, Teshima T, Makino S, Takamatsu Y, Akashi K, et al.. Cryopreservation, cytokine mobilization, and autotransplantation of peripheral blood stem cells. Prog Clin Biol Res 1992;377:297–308.
   PubMedGoogle Scholar
• Zambelli A, Poggi G, Da Prada GA, Pedrazzoli P, Cuomo A, Miotti D, et al.. Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res 1998;18:4705–8.
   PubMed Web of Science ®Google Scholar
• Alessandrino EP, Bernasconi P, Caldera D, Colombo A, Bonfichi M, Malcovati L, et al.. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. Bone Marrow Transplant 1999;23:533–7.
   PubMed Web of Science ®Google Scholar
• Donmez A, Tombuloglu M, Gungor A, Soyer N, Saydam G, Cagirgan S. Clinical side effects during peripheral blood progenitor cell infusion. Transfus Apher Sci 2007;36:95–101.
   PubMed Web of Science ®Google Scholar
• Nishihara G, Sakemi T, Ikeda Y, Baba N, Shimamoto Y. Multiple organ failure associated with dimethylsulfoxide and hydroxyethyl starch in autologous blood stem cell transplantation. Nephron 1996;72:356–7.
   PubMed Web of Science ®Google Scholar
• Bauwens D, Hantson P, Laterre PF, Michaux L, Latinne D, De Tourtchaninoff M, et al.. Recurrent seizure and sustained encephalopathy associated with dimethylsulfoxide-preserved stem cell infusion. Leuk Lymphoma 2005;46:1671–4.
   PubMed Web of Science ®Google Scholar
• Calmels B, Houzé P, Hengesse JC, Ducrot T, Malenfant C, Chabannon C. Preclinical evaluation of an automated closed fluid management device: Cytomate™, for washing out DMSO from hematopoietic stem cell graftsafter thawing. Bone Marrow Transplant 2003;31:823–8.
   PubMed Web of Science ®Google Scholar
• Rodríguez L, Velasco B, García J, Martín-Henao GA. Evaluation of an automated cell processing device to reduce thedimethyl sulfoxide from hematopoietic grafts after thawing. Transfusion 2005;45:1391–7.
   PubMed Web of Science ®Google Scholar
• Akkök ÇA, Holte MR, Tangen JM, Ostenstad B, Bruserud O. Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells. Transfusion 2009;49:354–61.
   PubMed Web of Science ®Google Scholar
• Kamata Y, Takahashi Y, Iwamoto M, Matsui K, Murakami Y, Muroi K, et al.. Local implantation of autologous mononuclear cells from bone marrow and peripheral blood for treatment of ischaemic digits in patients with connective tissue diseases. Rheumatology 2007;6:882–4.
   Google Scholar
• Muroi K, Handa K, Amemiya Y, Hakomori S, Ozawa K, Miura Y. Expression profiles of I and sialosyl-I antigens on blood cells: the sialosyl-I antigen is expressed along the monocytic differentiation. Leuk Res 1998;22:1029–36.
   PubMed Web of Science ®Google Scholar
• Matsumoto N, Yoshizawa H, Kagamu H, Abe T, Fujita N, Watanabe S, et al.. Successful liquid storage of peripheral blood stem cells at subzero non-freezing temperature. Bone Marrow Transplant 2002;30:777–84.
   PubMed Web of Science ®Google Scholar
• Ayello J, Semidei-Pomales M, Preti R, Hesdorffer C, Reiss RF. Effects of long-term storage at -90 degrees C of bone marrowand PBPC on cell recovery, viability, and clonogenic potential. J Hematother 1998;7:385–90.
   PubMedGoogle Scholar
• Korbling M, Huh YO, Durett A, Mirza N, Miller P, Engel H, et al.. Allogeneic blood stem cell transplantation: peripheralization and yield of donorderived primitive hematopoietic progenitor cells (CD34+Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood 1995;86:2842–8.
   PubMed Web of Science ®Google Scholar
• Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, et al.. Chronic graftversus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980;69:204–17.
   PubMed Web of Science ®Google Scholar
• Parimon T, Au DH, Martin PJ, Chien JW. A risk score for mortality after allogeneic hematopoietic cell transplantation. Ann Intern Med 2006;144:407–14.
   PubMed Web of Science ®Google Scholar
• http://www.r-project.org
   Google Scholar
• Watanabe T, Takaue Y, Kawano Y. Peripheral blood stem cell transplantation: an update. J Med Invest 1997;44:25–31.
   PubMedGoogle Scholar
• http://www.jmdp.or.jp/documents/file/07_about_us/chukantoshin.pdf#search = 'PB (in Japanese).
   Google Scholar
• Haas R, Mohle R, Fruhauf S, Goldschmidt H, Witt B, Flentje M, et al.. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994;83:3787–94.
   PubMed Web of Science ®Google Scholar
• Carral A, de la Rubia J, Martín G, Mollá S, Martínez J, Sanz GF, et al.. Factors influencing the collection of peripheral blood stem cell collection in patients with acute myeloblastic leukemia and non-myloid malignancies. Leuk Res 2003;27:5–12.
   PubMed Web of Science ®Google Scholar
• Kasparu H, Krieger O, Girschikofsky M, Kolb A, Bettelheim P, Lutz D. Factors influencing the timing of peripheral blood stem cell collection (PBSC). Transfus Apheresis Sci 1996;17:595–600.
   Google Scholar
• de la Rubia J, Arbona C, de Arriba F, del Cañizo C, Brunet S, Zamora C, et al.. Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors. Transfusion 2002;42:4–9.
   PubMed Web of Science ®Google Scholar
• Stockerl-Goldstein KE, Reddy SA, Horning SF, Blume KG, Chao NF, Hu WW, et al.. Favorable treatment outcome in non-Hodgkin’s lymphoma patients with ‘poor’ mobilization of peripheral blood progenitor cells. Biol Blood Marrow Transplant 2000;6:506–12.
   PubMed Web of Science ®Google Scholar